LAV Biosciences Fund V L.P. 13D and 13G filings for Gracell Biotechnologies Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:26 pm Unchanged |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
LAV Biosciences Fund V L.P. | 25,406,680 5.300% |
0 (Unchanged) |
Filing |
| 2022-02-09 12:17 pm Purchase |
2021-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
LAV Biosciences Fund V L.P. | 25,406,680 7.800% |
25,406,680 (New Position) |
Filing |